Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECJ: centres of excellence must be available to EU citizens:

This article was originally published in Clinica

Executive Summary

EU member states must bear the costs of treatment for their citizens when in another member state, even if the other member state treating the patient decides that the patient needs treatment in a third, non-member country. That is the conclusion reached by the European Court of Justice on April 12 2005, in case C145/03. This has significant implications for patients needing to have access to the latest treatments or medical technologies that may only be available in a few countries and not in the EU. In this case the patient, a Spanish resident, had a malignant tumour liable to cause imminent death which doctors in Germany decided could only be treated with a real chance of success in the Zurich University Clinic in Switzerland, not an EU member. "It is of no importance that the state to which the doctors have decided to transfer the patient is not a member of the EU", the ECJ concluded.

You may also be interested in...



Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054833

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel